nach oben

Neurological Sciences

Erschienen in:

01.08.2016 | Original Article

A novel oxidative stress marker in migraine patients: dynamic thiol–disulphide homeostasis

verfasst von: Sadiye Gumusyayla, Gonul Vural, Hesna Bektas, Salim Neselioglu, Orhan Deniz, Ozcan Erel

Erschienen in: Neurological Sciences | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to investigate dynamic thiol–disulphide homeostasis as a novel oxidative stress parameter in migraine patients. A total of 115 participants were included in the study, and 63 of whom were diagnosed with migraine. The total thiol (–SH+–S-S–) and native thiol (–SH) levels in the serum were measured in all patients and healthy individuals. The dynamic disulphide bond (–S-S–) and (–S-S–) × 100/(–SH), (–S-S–) × 100/(–SH+–S-S–), and –SH × 100/(–SH+–S-S–) ratios were calculated from these values. The total and native thiol levels of migraine patients participating in the study were found to be significantly higher than the total and native thiol levels of healthy individuals. No statistically significant difference was determined in terms of the dynamic disulphide bond amounts or (–S-S–) × 100/(–SH), (–S-S–) × 100/(–SH+–S-S–), and –SH × 100/(–SH+–S-S–) ratios. The total thiol, native thiol, and dynamic disulphide bond levels, and (–S-S–) × 100/(–SH), (–S-S–) × 100/(–SH+–S-S–), and –SH × 100/(–SH+–S-S–) ratios were not correlated with attack frequency, pain intensity, or migraine type. Oxidative stress is considered to be one of the molecular changes underlying the pathogenesis of migraine.

Goadsby PJ (2006) Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 13:39–44CrossRefPubMed

Yaltkaya K, Balkan S, Oguz Y (1994) Nöroloji Ders Kitabı. Palme Yayıncılık, Ankara

Silberstein SD, Lipton RB, Goodsby PJ (1998) Headeche in Clinical Practise. Isıs Medical Media pres, Oxford

Pietrobon D, Striessnig J (2003) Neurobiology of migraine. Nat Rev Neurosci 4:386–398CrossRefPubMed

Goadsby PJ, Lipton R, Ferrari M (2002) Migraine: current understanding and management. N Engl J Med 346(4):257–270CrossRefPubMed

Bolay H, Reuter U, Dunn A, Huang Z, Boas DA (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8(2):136–142CrossRefPubMed

Moskowitz MA (1992) Neurogenic versus vascular mechanism in migraine headaches. Trend Pharmacol Sci 13:307–311CrossRef

Pizza AV, Agresta A, Iorio EL, Capasso A (2013) Impaired oxidative balance in migraine: the evidence from d-ROMs test and bap test. Pharmakologyonline 1:25–28

Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidatives stress. Nat Rev Drug Discov 3:205–214CrossRefPubMed

10.

Sahin DY, Elbasan Z, Gür M, Türkoğlu C, Özaltun B, Sümbül Z, Çaylı M (2012) Relationship between oxidative stress markers and cardiac syndrome X. J Clin Exp Invest 3:174–180CrossRef

11.

Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, Dhama K (2014) Oxidative stress, prooxidants, and antioxidants: the interplay. Biomed Res Int 2014:1–19. doi:10.1155/2014/761264 CrossRef

12.

Cremers CM, Jakob U (2013) Oxidant sensing by reversible disulfide bond formation. J Biol Chem 288:26489–26496CrossRefPubMedPubMedCentral

13.

Turell L, Radi R, Alvarez B (2013) The thiol pool in human plasma: the central contribution of albumin to redox processes. Free Radic Biol Med 65:244–253CrossRefPubMedPubMedCentral

14.

Erel O, Neselioglu S (2014) A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem 47:326–332CrossRefPubMed

15.

Shimomura T, Murakami F, Kotani K, Ikawa S, Kono S (1999) Platelet nitric oxide metabolites in migraine. Cephalalgia 19:218–222CrossRefPubMed

16.

Stepien A, Chalimoniuk M, Stepien A (1998) Level of nitric oxidedependent cGMP in patients with migraine. Cephalalgia 18:631–634CrossRefPubMed

17.

Mecocci P, MacGarvey U, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann Neurol 36:747–751CrossRefPubMed

18.

Shahlaa HA, Hamadi SA, Ashwaq NAJ (2007) Effect of ergotamine and its combination with vitamin E or melatonin on total antioxidant status in migraine patients. Iraqi J Pharm Sci 16(2):27–33

19.

Maes M, Galecki P, Chang YS, Berk M (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 35:676–692CrossRefPubMed

20.

Kong Q, Lin CLG (2010) Oxidative damage to RNA: mechanisms, consequences, and diseases. Cell Mol Life Sci 67:1817–1829CrossRefPubMedPubMedCentral

21.

Wasterlain CG, Fujikawa DG, Penix L, Sankar R (1993) Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 34:37–53CrossRef

22.

Shin EJ, Jeong JH, Chung YH, Kim WK, Ko KH, Bach JH, Hong JS, Yoneda Y, Kim HC (2011) Role of oxidative stress in epileptic seizures. Neurochem Int 59:122–137CrossRefPubMedPubMedCentral

23.

Shukla R, Barthwal MK, Srivastava N, Sharma P, Raghavan SA, Nag D, Srimal RC, Seth PK, Dikshit M (2004) Neutrophil-free radical generation and enzymatic antioxidants in migraine patients. Cephalalgia 24:37–43CrossRefPubMed

24.

Tozzi-Ciancarelli MG, De Matteis G, Di Massimo C, Marini C, Ciancarelli I, Carolei A (1997) Oxidative stress and platelet responsiveness in migraine. Cephalalgia 17:580–584CrossRefPubMed

25.

Ciancarelli I, Tozzi-Ciancarelli MG, Di Massimo C, Marini C, Carolei A (2003) Urinary nitric oxide metabolites and lipid peroxidation by products in migraine. Cephalalgia 23:39–42CrossRefPubMed

26.

Erdal N, Altunkaynak Y, Altunkaynak E, Öztürk M, Mutluay B, Köksal A, Baybaş S (2005) Migrenli Hastalarda Oksidatif Stresin Göstergesi Olarak Lipid Peroksidasyonunun İncelenmesi. Düşünen Adam 18(3):129–135

27.

Selmaj K, De Belloroche J, Clifford Rose F (1988) Leukotriene B generation by polymorphonuclear leukocytes: possible involvement in the pathogenesis of headache. Headache 26:460–464CrossRef

28.

Lucchesi C, Baldacci F, Cafalli M, Chico L, Lo Gerfo A, Bonuccelli U, Siciliano G, Gori S (2015) Evidences of reduced antioxidant activity in patients with chronic migraine and medication-overuse headache. Headache 55(7):984–991CrossRefPubMed

29.

Ciancarelli I, Tozzi-Ciancarelli MG, Spacca G, Di Massimo C, Carolei A (2007) Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia 27(10):1136–1141CrossRefPubMed

30.

Shimomura T, Kowa H, Nakano T, Kitano A, Marukawa H, Urakami K, Takahashi K (1994) Platelet superoxidedismutase in migraine and tension-type headache. Cephalalgia 14:215–218CrossRefPubMed

31.

Yıldırım S, Akar S, Kuyucu M, Yıldırım A, Dane S, Aygül R (2011) Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine. Cell Biochem Funct 29(7):549–554CrossRefPubMed

32.

Yilmaz N, Aydin O, Yegin A, Tiltak A, Eren E (2011) Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs. Clin Biochem 44(10–11):832–837CrossRefPubMed

33.

García-Martín E, Martínez C, Serrador M, Alonso-Navarro H, Navacerrada F, Agúndez JA, Jiménez-Jiménez FJ (2010) Paraoxonase 1 (PON1) polymorphisms and risk for migraine. J Neurol 257(9):1482–1485CrossRefPubMed

34.

Alp R, Selek S, Alp SI, Taşkin A, Koçyiğit A (2010) Oxidative and antioxidative balance in patients of migraine. Eur Rev Med Pharmacol Sci 14(10):877–882PubMed

35.

Bolayir E, Celik K, Kugu N, Yılmaz A, Topaktaş S, Bakır S (2004) Intraerythrocyte antioxidant enzyme activities in migraine and tension-type headaches. J Chin Med Assoc 67:263–267PubMed

36.

Calabrese V, Lodi R, Tonon C, D’Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA (2005) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich’s ataxia. J Neurol Sci 233(1–2):145–162CrossRefPubMed

37.

Smeyne M, Smeyne RJ (2013) Glutathione metabolism and Parkinson’s disease. Free Radic Biol Med 62:13–25CrossRefPubMedPubMedCentral

38.

Steele ML, Fuller S, Maczurek AE, Kersaitis C, Ooi L, Münch G (2013) Chronic inflammation alters production and release of glutathione and related thiols in human U373 astroglial cells. Cell Mol Neurobiol 33(1):19–30CrossRefPubMed

39.

Eren Y, Dirik E, Neşelioğlu S, Erel Ö (2015) Oxidative stress and decreased thiol level in patients with migraine: cross-sectional study. Acta Neurol Belg 115(4):643–649CrossRefPubMed

40.

Atmaca G (2004) Antioxidant effects of sulfur-containing amino acids. Yonsei Med J 45:776–788CrossRefPubMed

41.

Lynch SM, Compine AL, Moore MK (2000) Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Biochim Billphys Acta 1485:11–22CrossRef

42.

Yardım-Akaydın S, Ozkan Y, Ozkan C, Torun M, Şimşek B (2003) The role of plasma thiols compounds and antioxidant vitamins in patients with cardiovascular diseases. Clinica Chimica Acta 338:99–105CrossRef

43.

Fang YZ, Yang S, Wu G (2002) Free radicals, antioxidants and nutrition. Nutrition 18:872–879CrossRefPubMed

Titel: A novel oxidative stress marker in migraine patients: dynamic thiol–disulphide homeostasis
verfasst von: Sadiye Gumusyayla
Gonul Vural
Hesna Bektas
Salim Neselioglu
Orhan Deniz
Ozcan Erel
Publikationsdatum: 01.08.2016
Verlag: Springer Milan
Erschienen in: Neurological Sciences / Ausgabe 8/2016
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-016-2592-z

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

Evaluation of corneal parameters in patients with Parkinson’s disease

Validation of 5-item and 2-item questionnaires in Chinese version of Dizziness Handicap Inventory for screening objective benign paroxysmal positional vertigo

Frequency-specific alterations in the fractional amplitude of low-frequency fluctuations in amyotrophic lateral sclerosis

Monte Carlo cross-validation analysis screens pathway cross-talk associated with Parkinson’s disease

Highlights of the Issue 8, 2016